JAK2 and myeloproliferative neoplasm: Altogether, the systemic procoagulatory state, activated myeloid cells, and endothelial cells (which may harbor the JAK2 mutation) induce a prothrombotic milieu in an already vulnerable splanchnic system, subjecting MPN patients to a high risk of developing SVT.